Clinically approved combination immunotherapy: Current status, limitations, and future perspective.
Lu L, Zhan M, Li XY, Zhang H, Dauphars DJ, Jiang J, Yin H, Li SY, Luo S, Li Y, He YW.
Lu L, et al. Among authors: li y, li xy, li sy.
Curr Res Immunol. 2022 Jun 3;3:118-127. doi: 10.1016/j.crimmu.2022.05.003. eCollection 2022.
Curr Res Immunol. 2022.
PMID: 35676925
Free PMC article.
Review.